Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Blann

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Heart (British Cardiac Society)|October 12, 2005
Antiplatelet therapy and the vascular treeA Blann
Journal of Internal Medicine|May 1, 1993
von Willebrand factor antigen, atherothrombotic mechanisms and smokingA Blann
Thrombosis and Haemostasis|March 2, 1992
Changes in von Willebrand factor antigen levels in venous occlusionA Blann
Thrombosis and Haemostasis|January 17, 2003
Comment: raised soluble P selectin and the risk of thrombosis in HIV-1 infectionA Blann
British Journal of Biomedical Science|June 1, 1993
von Willebrand factor and the endothelium in vascular diseaseA Blann
British Journal of Biomedical Science|October 9, 2018
British Journal of Biomedical Science in 2018: what have we learned?A Blann
British Journal of Biomedical Science|December 11, 2019
British Journal of Biomedical Science in 2019. What have we learned?A Blann
Archives of Internal Medicine|July 12, 1993
Distribution of lipid phenotypes in community-living men with coronary heart diseaseA Blann, M Porter
Clinical Hemorheology and Microcirculation|January 1, 1997
Soluble markers of endothelial cell functionA Blann, M Seigneur
Journal of Thrombosis and Haemostasis : JTH|March 11, 2004
Ethnic background is a determinant of average warfarin dose required to maintain the INR between 3.0 and 4.5A Blann, D Bareford
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Heart (British Cardiac Society)|October 12, 2005
Antiplatelet therapy and the vascular treeA Blann
Journal of Internal Medicine|May 1, 1993
von Willebrand factor antigen, atherothrombotic mechanisms and smokingA Blann
Thrombosis and Haemostasis|March 2, 1992
Changes in von Willebrand factor antigen levels in venous occlusionA Blann
Thrombosis and Haemostasis|January 17, 2003
Comment: raised soluble P selectin and the risk of thrombosis in HIV-1 infectionA Blann
British Journal of Biomedical Science|June 1, 1993
von Willebrand factor and the endothelium in vascular diseaseA Blann
British Journal of Biomedical Science|October 9, 2018
British Journal of Biomedical Science in 2018: what have we learned?A Blann
British Journal of Biomedical Science|December 11, 2019
British Journal of Biomedical Science in 2019. What have we learned?A Blann
Archives of Internal Medicine|July 12, 1993
Distribution of lipid phenotypes in community-living men with coronary heart diseaseA Blann, M Porter
Clinical Hemorheology and Microcirculation|January 1, 1997
Soluble markers of endothelial cell functionA Blann, M Seigneur
Journal of Thrombosis and Haemostasis : JTH|March 11, 2004
Ethnic background is a determinant of average warfarin dose required to maintain the INR between 3.0 and 4.5A Blann, D Bareford
Pageof 5